GlucoModicum’s non-invasive glucose monitoring technology performs 13x better than previous needle-free approaches
GlucoModicum 's Not - - invasive glucose monitoring technology Performance 13x better than previous needle - - free approaches - Data published in Scientific Reports, part of the Nature Portfolio Journals, paves the way for groundbreaking wearable solutions for monitoring diabetes - Helsinki, Finland , April 20, 2021 - GlucoModicum, an innovator in needle-free health and biomarker monitoring solutions, announces that research data on its proprietary magnetohydrodynamics ("MHD") technology to measure glucose levels in the skin without needles has been published in Scientific Reports, Part 1 of the Nature Research portfolio, the world's leading multidisciplinary scientific journals. These peer-reviewed results show that GlucoModicum's novel approach to dermal interstitial fluid collection was 13 times faster and more effective than its predecessor, reverse iontophoresis. Blood glucose testing is critical to the diagnosis and treatment of diab